A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)
Clinical trial NCT03648281 · COMPLETED
Trial details
- NCT number
- NCT03648281
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-08-24
- Primary completion
- 2020-01-10
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.